Directory
>
Mertie Snead
Mertie Snead
Executive Director Global Vaccine Safety Compliance | Novavax
Raleigh, North Carolina, United States
Mertie Snead
Summary
Mertie Snead is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Director of Global Vaccine Safety Compliance at Novavax Inc. With a career spanning over three decades, Mertie has held various leadership roles focused on compliance and quality assurance in the biotech and pharmaceutical sectors. Her expertise includes regulatory affairs, pharmacovigilance, and clinical research, making her a key player in ensuring drug safety and compliance. Mertie has a proven track record of leading cross-functional teams and implementing effective compliance strategies. She is passionate about advancing vaccine safety and regulatory practices, leveraging her extensive experience to influence industry standards. A graduate of North Carolina Central University, Mertie's commitment to excellence is evident in her long-standing tenure at renowned organizations such as Merck and GlaxoSmithKline. She is known for her strategic vision and dedication to fostering a culture of compliance within her teams.
Mertie Snead
Work Experience
Executive Director Global Vaccine Safety Compliance at
Novavax
April 2023 - Present
Senior Director Pharmacovigilance Compliance at
NOVAVAX LIMITED
December 2020 - April 2023
Director GCP Quality Assurance - Infectious Disease/Vaccines at
Merck
June 2018 - September 2020
Senior Director Compliance and Training/Safety Risk Management at
Icon
July 2016 - May 2018
Section Director Pharmacovigilance Quality and Compliance at
MedImmune
March 2013 - June 2016
Vice President GXP Compliance -Clinical Compliance Lead at
Compliance Implementation Services (CIS)
September 2011 - April 2012
Director, Global Quality and Compliance - Externalization at
GSK
April 1990 - October 2010
Mertie Snead
Education
North Carolina Central University
January 1980 - January 1984
Frequently Asked Questions about Mertie Snead
What is Mertie Snead email address?
Mertie Snead's primary email address is ******@novavax.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mertie Snead work for?
Mertie Snead is a Executive Director Global Vaccine Safety Compliance at Novavax, a company specializing in Biological products, except diagnostic.
Where Mertie Snead graduated from?
Mertie Snead holds a degree in from North Carolina Central University.
How can I directly contact Mertie Snead?
To contact Mertie Snead directly, you can use the email address ******@novavax.com. Complete contact information is available upon registration with Muraena.
Who is Mertie Snead?
Mertie Snead is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Director of Global Vaccine Safety Compliance at Novavax Inc. With a career spanning over three decades, Mertie has held various leadership roles focused on compliance and quality assurance in the biotech and pharmaceutical sectors. Her expertise includes regulatory affairs, pharmacovigilance, and clinical research, making her a key player in ensuring drug safety and compliance. Mertie has a proven track record of leading cross-functional teams and implementing effective compliance strategies. She is passionate about advancing vaccine safety and regulatory practices, leveraging her extensive experience to influence industry standards. A graduate of North Carolina Central University, Mertie's commitment to excellence is evident in her long-standing tenure at renowned organizations such as Merck and GlaxoSmithKline. She is known for her strategic vision and dedication to fostering a culture of compliance within her teams.
Mertie`s contact details
******@novavax.com
******@medimmune.com
Colleagues
Vice President, Vaccine Immunology
Advisor to the Board of Directors, Former CEO
Vice President Global Quality Assurance
Senior Calibration Technician
Quality Assurance Specialist III CMO | OJT Trainer | Quality Operations
Vice President, Vaccine Development
Vice President, Head of Global Medical Writing and Clinical Trial Transparency
President, Research and Development
Executive Director Clinical Outsourcing & Business Operations
SVP Commercial Operations